2020-12-03 08:22 Overview Target Drug Modality Indication Mechanism of Action Status Data Drug Name CD3xBCMA-bsAb Description CD3xBCMA-bsAb, a novel bispecific antibody concomitantly targeting BCMA, highly expressed on multiple myeloma (MM) cells, and CD3 on T cells, is obtained by self-developed human natural phage antibody display library. CD3xBCMA-bsAb directs the cytolytic activity of T cells selectively to MM &hellip